This news update regarding ECHA prioritising CMR substances is brought to you by ECHA.
ECHA prioritising CMR substances.
ECHA’s new CMR report shows that companies are adhering well to the harmonised classification of substances which have carcinogenic, mutagenic or reprotoxic properties (CMRs). The report furthermore identifies over a thousand CMR substances that potentially merit further regulatory action such as harmonised classification and, where relevant, identification as Substance of Very High Concern. ECHA, together with Member State competent authorities is now prioritising such substances for appropriate risk management actions.
There are currently about 1 400 individual substances and 23 groups of substances with a harmonised CMR classification. They are listed in Annex VI of the Classification, Labelling and Packaging (CLP) Regulation. ECHA checked the notifications to the C&L Inventory against the harmonised classification and found that about 97 percent adhered to the regulation. The situation was even better for notifications derived from REACH registration dossiers.
ECHA will now refer 12 registrations for individual substances on Annex VI to the national enforcement authorities for follow-up as they are not in line with the requirements of the CLP Regulation. A further 49 registrations for the group entry for lead compounds were also found to not adhere to the regulation. In the follow up of these, the first step is to clarify the exact nature of the compounds. The Agency is therefore contacting the registrants directly to ask them to clarify their classifications. ECHA urges all companies to check and update their notifications if needed.
For more information regarding ECHA prioritising CMR substances please visit the ECHA link above. Please contact Nexreg for Regulatory Services.
